全文获取类型
收费全文 | 89371篇 |
免费 | 8002篇 |
国内免费 | 4314篇 |
专业分类
耳鼻咽喉 | 853篇 |
儿科学 | 1410篇 |
妇产科学 | 1703篇 |
基础医学 | 10061篇 |
口腔科学 | 1418篇 |
临床医学 | 11691篇 |
内科学 | 14156篇 |
皮肤病学 | 978篇 |
神经病学 | 5178篇 |
特种医学 | 2780篇 |
外国民族医学 | 25篇 |
外科学 | 9976篇 |
综合类 | 12359篇 |
现状与发展 | 9篇 |
一般理论 | 28篇 |
预防医学 | 7271篇 |
眼科学 | 2653篇 |
药学 | 8380篇 |
69篇 | |
中国医学 | 4172篇 |
肿瘤学 | 6517篇 |
出版年
2024年 | 323篇 |
2023年 | 1285篇 |
2022年 | 3034篇 |
2021年 | 4147篇 |
2020年 | 3170篇 |
2019年 | 2736篇 |
2018年 | 2978篇 |
2017年 | 2619篇 |
2016年 | 2641篇 |
2015年 | 3730篇 |
2014年 | 4632篇 |
2013年 | 4909篇 |
2012年 | 7432篇 |
2011年 | 7749篇 |
2010年 | 5066篇 |
2009年 | 4053篇 |
2008年 | 5281篇 |
2007年 | 5266篇 |
2006年 | 4981篇 |
2005年 | 4704篇 |
2004年 | 3569篇 |
2003年 | 3216篇 |
2002年 | 2731篇 |
2001年 | 1516篇 |
2000年 | 1385篇 |
1999年 | 1365篇 |
1998年 | 799篇 |
1997年 | 804篇 |
1996年 | 637篇 |
1995年 | 511篇 |
1994年 | 480篇 |
1993年 | 327篇 |
1992年 | 453篇 |
1991年 | 409篇 |
1990年 | 390篇 |
1989年 | 332篇 |
1988年 | 281篇 |
1987年 | 256篇 |
1986年 | 229篇 |
1985年 | 175篇 |
1984年 | 158篇 |
1983年 | 120篇 |
1982年 | 119篇 |
1981年 | 97篇 |
1980年 | 99篇 |
1979年 | 89篇 |
1978年 | 81篇 |
1977年 | 44篇 |
1975年 | 43篇 |
1974年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
78例病人接受冠脉造影和次极量平板运动试验,探讨Q-Tc、Q-Tr和△Q-Tc预测冠脉病变的准确性。Q-Tc与Q-Tr的敏感度,特异度,阳性预测值及诊断准确率分别为84,76,83,81%与69,88,89,77%,与ST段降低的相比无明显差别,提示其诊断价值相似。与心血管造影资料对照,上述指标能反映冠脉病变的程度。△Q-Tc的敏感度低(58%)而特异性高(94%),其诊断准确性(73%)与其他指标相比无显著差异,故有应用价值。 相似文献
42.
当归多糖及其中性组分对巨噬细胞分泌TNF-α的影响 总被引:18,自引:1,他引:17
目的 :观察当归多糖 (ASP)及其中性组分 (ASP 1)在体内外对小鼠腹腔巨噬细胞 (MФ)分泌TNF α的影响。方法 :直接制取小鼠腹腔MФ ,与ASP及ASP 1共同培养 16h ;ASP及ASP 112 5、2 5 0mg kg经口灌胃给药 7d ,于第 7d制取MФ ,体外培养 16h ,分别观察ASP及ASP 1在体外均可显著增强MФ对TNF α的分泌。ASP及ASP 1体内给药无直接诱导MФ分泌TNF α的功能。结论 :ASP及ASP 1在体内外均可增强小鼠腹腔MФ分泌TNF α的功能。 相似文献
43.
地尔硫卓联合地高辛治疗心力衰竭并慢性快速房颤分析 总被引:3,自引:1,他引:2
目的观察地尔硫卓联合小剂量地高辛对心力衰竭并慢性快速房颤患者血压、心室率和心功能的影响。方法 :心功能Ⅱ~Ⅲ级慢性房颤患者 10 6例 ,随机分为二组 ,对照组 5 0例 ,单用地高辛 ,治疗组 5 6例 ,地尔硫卓与地高辛联用 ,其余治疗二组相同 ,7~ 10d为一疗程 ,观察治疗前后血压、心率、左室射血分数 (LVEF)、心输出量 (CO)。结果 :治疗组较对照组心室率明显下降 ,控制满意 ,血压、LVEF及CO变化二组相似。结论 :地尔硫卓联合小剂量地高辛治疗心衰并慢性快速房颤患者心室率较单用地高辛效果更好 ,且较为安全。 相似文献
44.
45.
为探讨医院内细菌感染的流行病学特点,作者借助临床分离的64株肺为克雷伯菌,45株阴沟肠杆菌和63株醋酸钙不动杆菌,进行质粒图谱分3种细菌分别有58株,35株和41株含有质粒,且分别构成46个,21个和23个质粒图谱型。结果表明:质粒分析为查明医院内细菌感染源和感染途径提供了较为直接,准确的客观依据,同时也看到了质粒分析的局限性。 相似文献
46.
对离体不同时间血痕进行肉眼和扫描电镜观察,获得了血痕形态结构变化的初步认识.结果随时间延长,血痕逐渐干燥、龟裂,电镜下纤维蛋白网消失,其超微结构变化观察有助于血痕经过时间的推断. 相似文献
47.
Jeffrey A. Gray Stephen N. Mitchell Michael H. Joseph Grigory A. Grigoryan Sharon Dawe Helen Hodges 《Drug development research》1994,31(1):3-17
Data are reviewed, largely from experiments in the authors'laboratory, that suggest three modes of action of systemic nicotine in producing three different types of effect upon behavior and cognitive function. (1) Preexposure of a stimulus without consequence makes it harder subsequently to form associations to that stimulus, a form of selective attention known as latent inhibition. Latent inhibition is blocked by nicotine, an effect that is apparently mediated by a nicotine-induced increase in dopamine release in the nucleus accumbens. (2) A single dose of nicotine proactively increases the partial reinforcement extinction effect measured several weeks later: that is, resistance to extinction is decreased by nicotine in animals that have been trained on a continuous reinforcement schedule, and increased in animals trained on a partial reinforcement schedule. This effect appears to be due to increased synthesis of tyrosine hydroxylase in the cell bodies of noradrenergic neurons in the locus coeruleus, followed by axonal transport to the hippocampus and increased synthesis and release of noradrenaline in that structure. (3) Nicotine improves vigilance in animals with cognitive deficits due to destruction of the forebrain cholinergic projection system, either as a consequence of excitotoxic lesions of the nuclei of origin of this system or after prolonged alcohol consumption; and also in human subjects with Alzheimer's disease (in which this system undergoes degeneration). This effect is most likely due to an action at denervated cholinergic synapses in the hippocampus and neocortex. © 1994 Wiley-Liss, Inc. 相似文献
48.
49.
Many degenerative human diseases reflect damage to cells that are not normally repaired or replaced, such as diabetes, Parkinson's disease, hepatic failure and congestive heart failure. Preliminary studies in animals and humans have suggested that these diseases may be treatable by transplantation of healthy cells. Such cells may be obtained by in vitro culture of embryonic stem cells, which are capable of differentiating into many cell types. This review discusses applicative approaches for the derivation, maintenance and safety of human embryonic stem (hES) cells as well as ethical concerns surrounding their possible source for cellular therapy. hES cells offer broad application in cellular therapy; however, this review specifically emphasizes on cardiovascular repair, generation and characterization of hES cell-derived cardiomyocytes, vascular progenitors and differentiation of derivatives. 相似文献
50.
Benjamin H. S. Lau Sharon K. Riesen Kim P. Truong Esther W. Lau Peter Rohdewald Ray A. Barreta 《The Journal of asthma》2004,41(8):825-832
A randomized, placebo-controlled, double-blind study involving 60 subjects, aged 6-18 years old, was conducted over a period of 3 months to determine the effect of Pycnogenol® (a proprietary mixture of water-soluble bioflavonoids extracted from French maritime pine) on mild-to-moderate asthma. After baseline evaluation, subjects were randomized into two groups to receive either Pycnogenol® or placebo. Subjects were instructed to record their peak expiratory flow with an Assess® Peak Flow Meter each evening. At the same time, symptoms, daily use of rescue inhalers (albuterol), and any changes in oral medications were also recorded. Urine samples were obtained from the subjects at the end of the run-in period, and at 1-, 2-, and 3-month visits. Urinary leukotriene C4/D4/E4 was measured by an enzyme immunoassay. Compared with subjects taking placebo, the group who took Pycnogenol® had significantly more improvement in pulmonary functions and asthma symptoms. The Pycnogenol® group was able to reduce or discontinue their use of rescue inhalers more often than the placebo group. There was also a significant reduction of urinary leukotrienes in the Pycnogenol® group. The results of this study demonstrate the efficacy of Pycnogenol® as an adjunct in the management of mild-to-moderate childhood asthma. 相似文献